Press Releases

Sensus Healthcare Granted U.S. Patent for Three-Dimensional Beam Forming X-Ray Source

Patent covers beam splitting and sculpting capabilities of radiation to treat all types of solid tumors with Sculptura™ and potentially other devices BOCA RATON, Fla, Feb. 23, 2021 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced that […]

Sensus Healthcare to Host Fourth Quarter 2020 Financial Results and Business Update Conference Call on February 25, 2021

BOCA RATON, Fla, Feb. 18, 2021 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 25, 2021 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter […]

Holy Name Medical Center in Teaneck, New Jersey Acquires Sensus Healthcare's Low-dose Radiation Therapy System to Treat Pneumonia in COVID-19 Patients

BOCA RATON, Fla., Jan. 06, 2021 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced Holy Name Medical Center in Teaneck, New Jersey has acquired a Sensus low-dose radiation therapy system for the treatment of pneumonia in COVID-19 […]

Sensus Healthcare Engages Ekpac Healthcare Ltd. as New Exclusive Distributor in China for SRT-100™ Systems

Agreement is for the treatment of non-melanoma skin cancer and keloids, covers China and Hong Kong and is effective January 1, 2021 BOCA RATON, Fla., Dec. 15, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that it […]

Sensus Healthcare Announces CMS Sets Rates Higher for SRT Reimbursement

Centers for Medicare & Medicaid Services sets a 66% increase in reimbursement for Radiation Treatment Delivery code 77401, and increases related Evaluation & Management codes Rates to go into effect as of January 1, 2021 BOCA RATON, Fla, Dec. 08, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, […]

Sensus Healthcare Announces Study Showing Single Low Dose of Superficial Radiation Therapy Prevents Keloid Recurrence Following Surgical Excision

Prospective study published in Journal of the American Academy of Dermatology BOCA RATON, Dec. 01, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the publication of a prospective clinical study showing that a single low dose of […]

« Previous 1 2 3 4 5 6 7 8 9 10 11 … 19 20 21 22 23 24 25 26 27 28 Next »